Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Elan Corporation (ELN)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for ELN as compared to
Top Competitors
Drug Manufacturers - Other
Biotechnology
Drug Delivery
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
1.07B
AVG
EBITDA
►
-102M
LOW
Net Income
►
-84.8M
LOW
Revenue Growth
►
42.7%
AVG
Operating Margin
►
-8.9%
AVG
Net Margin
►
-8%
AVG
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-5.51
Current Ratio
►
2.04
AVG
Quick Ratio
►
2.04
AVG
Interest Coverage Ratio
►
-0.974
AVG
Book Value Per Share
►
-0.790
Cash Per Share
►
0.459
Loading...
STOCK SUMMARY
Open
6.51
Day Range
6.45
-
6.63
52 Week Range
4.61
-
9.13
Volume
2.63M
Avg Volume (3 mo)
4.63M
Shares Outstanding
480M
Market Cap
3.05B
VALUATION
Price to Earnings (P/E)
►
-39.5
Price to Book (P/B)
►
-8.93
Price to Sales (P/S)
►
3.14
AVG
Return on Assets (ROA)
►
3.7%
AVG
EV/EBITDA
►
-52.5
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Held by institutions
48.6%
No Sales Breakout Data.